CRBU Stock Analysis: Buy, Sell, or Hold?
CRBU - Caribou Biosciences, Inc. Common Stock
$1.82
0.06 (3.41%)
▲
5d:
+15.92%
30d:
-21.55%
90d:
-8.54%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When CRBU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CRBU shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CRBU shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CRBU is currently trading at $1.82, which is considered fair relative to its 30-day fair value range of $1.61 to $2.14.
Technical Outlook: Technically, CRBU is in a strong uptrend. Immediate support is located at $1.59, while resistance sits at $2.15. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: CRBU has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+559.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRBU is in a strong uptrend. Immediate support is located at $1.59, while resistance sits at $2.15. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: CRBU has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+559.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.61 -
$2.14
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading 559.3% below Wall St target ($12.00)
Trading Range Analysis
30-Day Trading Range
$1.61 -
$2.14
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.59
Resistance Level
$2.15
Current Trend
Strong Uptrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.30
Wall Street Target
$12.00
(+559.3%)
Revenue Growth (YoY)
1.9%
Share & Embed Analysis
Last updated: July 02, 2026 10:48 PM ET
Data refreshes hourly during market hours. Next update: 11:48 PM
Data refreshes hourly during market hours. Next update: 11:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRBU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Barbara G Mcclung
SELL
6938 shares
2026-02-24
Ruhi Ahmad Khan
SELL
6938 shares
2026-02-24
Timothy P Kelly
SELL
3147 shares
2026-02-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$110 | 61 BUY |
